ClinicalTrials.Veeva

Menu

Optical Imaging For Assessment of Foot Perfusion

M

Modulated Imaging

Status

Unknown

Conditions

Diabetes
Ulcer Foot

Treatments

Device: SFDI Imaging

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT03144050
11150 (Registry Identifier)

Details and patient eligibility

About

This study is designed to evaluate the ability of Spatial Frequency Domain Imaging (SFDI) to measure perfusion in lower extremities and to understand how it might be used in a podiatry clinic.

Full description

This study is designed to evaluate the ability of Spatial Frequency Domain Imaging (SFDI) to measure perfusion in lower extremities and to understand how it might be used in a podiatry clinic. SFDI is a non-contact optical imaging technology that measures tissue functional (blood volume, tissue oxygen saturation) and structural information (scattering index) across a large field of view. Our hypothesis is that SFDI parameters can eventually become a quantitative tool to assess foot health and identify patients at risk for ulcer formation. This phase of the study is designed to correlate SFDI outputs to current clinical risk categories

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Exclusion criteria

  • Pregnant/lactating women
  • Rheumatoid arthritis

Trial design

400 participants in 6 patient groups

0
Description:
Control - no diabetes
Treatment:
Device: SFDI Imaging
1
Description:
Diabetes
Treatment:
Device: SFDI Imaging
2
Description:
Diabetes w/neuropathy
Treatment:
Device: SFDI Imaging
3
Description:
Diabetes with vascular disease
Treatment:
Device: SFDI Imaging
4
Description:
Diabetes w/healed ulcer
Treatment:
Device: SFDI Imaging
5
Description:
Diabetes with current ulcer
Treatment:
Device: SFDI Imaging

Trial contacts and locations

1

Loading...

Central trial contact

Kalvin Yu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems